SKI Market

Indian Indices

Nifty

25,509.70 -87.95
(-0.34%)

Sensex

83,216.28 -94.73
( -0.11%)

Bank Nifty

57,554.25 -272.80
( -0.47%)

Nifty IT

35,337.60 63.05
( 0.18%)

Global Indices

Nasdaq

46,931.02 -400.98
(-0.85%)

Dow Jones

6,741.06 -76.23
(-1.12%)

Hang Seng

50,211.07 -672.61
(-1.32%)

Nikkei 225

9,736.38 -40.70
(-0.42%)

Forex

USD-INR

88.65 -0.03
(-0.04%)

EUR-INR

101.82 -0.15
(-0.14%)

GBP-INR

115.54 -0.38
(-0.33%)

JPY-INR

0.58 0.00
(-0.08%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Strides Pharma Science Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532531

INE939A01011

344.5797109

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

STAR

115.63

8845.82

EPS(TTM)

Face Value()

Div & Yield %

8.3

0.42

Back

kaizen agro infrabuild ltd

Shriram Finance standalone net profit rises 11.39% in the September 2025 quarter

Oct 31,2025

Net profit of Shriram Finance rose 11.39% to Rs 2307.18 crore in the quarter ended September 2025 as against Rs 2071.26 crore during the previous quarter ended September 2024. Sales rose 18.02% to Rs 11907.79 crore in the quarter ended September 2025 as against Rs 10089.54 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	11907.79	10089.54	18
OPM %	73.90	71.89	-
PBDT	3284.46	2910.39	13
PBT	3110.02	2751.53	13
NP	2307.18	2071.26	11

25,509.70 -87.95 (-0.34%)

83,216.28 -94.73 ( -0.11%)

57,554.25 -272.80 ( -0.47%)

35,337.60 63.05 ( 0.18%)

46,931.02 -400.98 (-0.85%)

6,741.06 -76.23 (-1.12%)

50,211.07 -672.61 (-1.32%)

9,736.38 -40.70 (-0.42%)

88.65 -0.03 (-0.04%)

101.82 -0.15 (-0.14%)

115.54 -0.38 (-0.33%)

0.58 0.00 (-0.08%)